LPL

LPL

Target · Lipase enzyme

LPL Lipoprotein lipase · LIPD

LPL (lipoprotein lipase, also known as LIPD) is a key enzyme in triglyceride metabolism. It hydrolyses triglycerides carried by circulating chylomicrons and very low density lipoproteins, clearing lipid from the blood stream for use and storage. Browse Assay Genie's current range of LPL research reagents below, or read on for the biology behind the target.

Secreted and cell membraneTriglyceride lipaseLinked to hyperlipoproteinemia
475 aa
Protein length
~53 kDa
Molecular weight
8p21.3
Gene locus
EC 3.1.1.34
Enzyme class
Target information

What is LPL (lipoprotein lipase)?

LPL catalyses the hydrolysis of triglycerides from circulating chylomicrons and very low density lipoproteins (VLDL), and so plays an important role in lipid clearance from the blood stream, lipid utilisation and storage. It has both phospholipase and triglyceride lipase activities, but it is primarily a triglyceride lipase, with low but detectable phospholipase activity. LPL also mediates margination of triglyceride-rich lipoprotein particles in capillaries. It is recruited to its site of action on the luminal surface of vascular endothelium by binding to GPIHBP1 and to cell surface heparan sulfate proteoglycans.

The LPL gene encodes lipoprotein lipase, which is expressed in heart, muscle and adipose tissue. The protein functions as a homodimer and has two roles: as a triglyceride hydrolase, and as a ligand or bridging factor for receptor-mediated lipoprotein uptake. Consistent with this, the LPL protein is found at the cell membrane and is secreted into the extracellular space and extracellular matrix. It belongs to the lipase family within the AB hydrolase superfamily, and HGNC places the gene in the lipases group. Mouse and rat each have an orthologous Lpl gene.

LPL is relevant to disease. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in the LPL gene are linked to many disorders of lipoprotein metabolism. This makes LPL a central subject for researchers studying lipid transport, triglyceride handling and the vascular endothelial surface where the enzyme acts.

Triglyceride metabolism

LPL is a key enzyme in triglyceride metabolism, hydrolysing triglycerides from chylomicrons and VLDL to support lipid utilisation and storage.

Lipoprotein metabolism disorders

Severe LPL mutations cause type I hyperlipoproteinemia, and milder variants are linked to many disorders of lipoprotein metabolism.

Vascular endothelium biology

LPL acts on the luminal endothelial surface, where binding to GPIHBP1 and heparan sulfate proteoglycans recruits it and supports lipoprotein margination.

Adipose and muscle research

LPL is expressed in heart, muscle and adipose tissue, making it relevant to studies of tissue lipid uptake and storage.

Background

LPL frequently asked questions

What does LPL do?

LPL hydrolyses triglycerides in circulating chylomicrons and VLDL, contributing to lipid clearance from the blood, and to lipid utilisation and storage. It is primarily a triglyceride lipase with low phospholipase activity, and it also acts as a bridging factor for receptor-mediated lipoprotein uptake.

What other names does LPL go by?

LPL is the HGNC symbol for lipoprotein lipase, and LIPD is a recorded alias. The enzyme carries the EC number 3.1.1.34. In mouse and rat, the orthologous gene is named Lpl. Check the datasheet of any product for its validated reactivity.

How is LPL linked to disease?

Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia. Less extreme mutations in the LPL gene are linked to many disorders of lipoprotein metabolism, reflecting the enzyme's central role in clearing triglyceride-rich lipoproteins.

Explore

Related targets

Binding partners and other lipases and lipid-metabolism targets related to LPL.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P06858; product specifications from Assay Genie datasheets.

LPL Product listing